Published in Bone Marrow Transplant on February 01, 1999
Adenoviruses in immunocompromised hosts. Clin Microbiol Rev (2008) 2.20
The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol (2008) 2.19
Multiplexed, real-time PCR for quantitative detection of human adenovirus. J Clin Microbiol (2003) 1.42
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant (2011) 1.28
Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy. J Virol (2003) 1.11
Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol (2005) 1.11
Real-time PCR with an internal control for detection of all known human adenovirus serotypes. J Clin Microbiol (2008) 1.09
Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay. J Clin Microbiol (2005) 1.09
Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase. J Virol (2004) 1.06
Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2012) 1.05
Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis (2004) 1.05
Acute kidney injury due to bilateral ureteral obstruction in children. World J Nephrol (2014) 0.99
Identification of quantitative trait loci for susceptibility to mouse adenovirus type 1. J Virol (2005) 0.95
Antiviral T-cell therapy. Immunol Rev (2014) 0.91
Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation. Expert Opin Biol Ther (2010) 0.91
Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice. J Virol (2012) 0.88
Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation. Virology (2006) 0.88
IL-17 contributes to neutrophil recruitment but not to control of viral replication during acute mouse adenovirus type 1 respiratory infection. Virology (2014) 0.87
Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation. Adv Hematol (2013) 0.87
Ultrasonography in the diagnosis of hemorrhagic cystitis - a complication of bone marrow transplantation in pediatric oncology patients. J Ultrason (2014) 0.86
Prospective detection of respiratory pathogens in symptomatic children with cancer. Pediatr Infect Dis J (2013) 0.85
Adenoviral infection presenting as an isolated central nervous system disease without detectable viremia in two children after stem cell transplantation. J Clin Microbiol (2011) 0.84
Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery. Antiviral Res (2012) 0.83
Identification of adenoviruses in specimens from high-risk pediatric stem cell transplant recipients and controls. J Clin Microbiol (2007) 0.83
PCR diagnostics and monitoring of adenoviral infections in hematopoietic stem cell transplantation recipients. Arch Virol (2010) 0.82
An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAs. Antiviral Res (2012) 0.80
Unique sequence features of the Human adenovirus 31 complete genomic sequence are conserved in clinical isolates. BMC Genomics (2009) 0.78
A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection. J Pediatr Hematol Oncol (2009) 0.77
Use of cidofovir in pediatric patients with adenovirus infection. F1000Res (2016) 0.75
A Rare Case of Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplant Patient. Indian J Hematol Blood Transfus (2015) 0.75
Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation. Pediatr Blood Cancer (2011) 0.75
Combinatorial targeting of 2 different steps in adenoviral DNA replication by herpes simplex virus thymidine kinase and artificial microRNA expression for the inhibition of virus multiplication in the presence of ganciclovir. BMC Biotechnol (2013) 0.75
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood (1998) 6.26
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet (1995) 4.07
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med (1996) 4.07
Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation. J Clin Invest (1966) 2.87
Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet (1993) 2.85
Determination of triiodothyronine concentration in human serum. J Clin Invest (1969) 2.56
Metabolite transfer via enzyme-enzyme complexes. Science (1986) 2.24
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. Leukemia (2010) 2.22
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood (2001) 2.20
Specific interaction of DNA polymerase beta and DNA ligase I in a multiprotein base excision repair complex from bovine testis. J Biol Chem (1996) 2.10
Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b. Infect Immun (1987) 2.06
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood (1998) 1.86
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol (1991) 1.82
Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J Hematother (1995) 1.71
Identification of 5'-deoxyribose phosphate lyase activity in human DNA polymerase gamma and its role in mitochondrial base excision repair in vitro. Proc Natl Acad Sci U S A (1998) 1.71
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet (1993) 1.53
Donor T cells to treat EBV-associated lymphoma. N Engl J Med (1994) 1.53
Correction of Duncan's syndrome by allogeneic bone marrow transplantation. Lancet (1993) 1.53
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet (1993) 1.51
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood (2001) 1.50
Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood (1994) 1.45
Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther (2001) 1.42
Conversion of thyroxine to triiodothyronine in normal human subjects. Science (1970) 1.42
Upper airway obstruction and pulmonary abnormalities due to lymphoproliferative disease following bone marrow transplantation in children. Pediatr Radiol (1998) 1.39
Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence. Infect Immun (1987) 1.38
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood (2000) 1.37
Enzyme-enzyme interactions and the regulation of metabolic reaction pathways. Curr Top Cell Regul (1986) 1.36
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer. Oncol Nurs Forum (1997) 1.32
Biophysical chemistry of metabolic reaction sequences in concentrated enzyme solution and in the cell. Annu Rev Biophys Biophys Chem (1987) 1.31
Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med (1993) 1.31
Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol (2000) 1.28
Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet (1997) 1.25
Sequence and analysis of the rpoB gene of Mycobacterium smegmatis. Antimicrob Agents Chemother (1995) 1.22
Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant (2004) 1.21
Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol (1995) 1.19
Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant (2005) 1.19
High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol (1993) 1.19
Multi-component behavioral intervention to promote health protective behaviors in childhood cancer survivors: the protect study. Med Pediatr Oncol (2002) 1.17
Hypermobility: prevalence and features in a Swedish population. Br J Rheumatol (1993) 1.16
Thyroid hormone action: the mitochondrial pathway. Science (1977) 1.16
Bacillus cereus bacteremia and meningitis in immunocompromised children. Clin Infect Dis (2001) 1.16
Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum Gene Ther (1994) 1.14
Pseudomonas aeruginosa bacteremia in immunocompromised children: analysis of factors associated with a poor outcome. Clin Infect Dis (1994) 1.14
Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood (1986) 1.14
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood (1987) 1.14
End-of-life decision making by adolescents, parents, and healthcare providers in pediatric oncology: research to evidence-based practice guidelines. Cancer Nurs (2001) 1.12
Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12
Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience. Leukemia (2003) 1.11
Up-regulation of base excision repair correlates with enhanced protection against a DNA damaging agent in mouse cell lines. Nucleic Acids Res (1998) 1.11
Repressive adaptation in children with cancer. Health Psychol (1997) 1.11
Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML). Bone Marrow Transplant (2006) 1.10
Isolation of soluble immune complexes by affinity chromatography using staphylococcal protein A--Sepharose as substrate. J Immunol Methods (1977) 1.10
Pseudomonas aeruginosa cellulitis and ecthyma gangrenosum in immunocompromised children. Pediatr Infect Dis J (1991) 1.09
Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. Transplantation (2001) 1.08
Conversion of thyroxine to triiodothyronine by cultured human cells. Science (1973) 1.06
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology (2008) 1.06
Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II. J Am Chem Soc (2004) 1.05
Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection. Avian Dis (1998) 1.05
Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant (2007) 1.05
Rapid effect of triiodothyronine on the mitochondrial pathway in rat liver in vivo. Science (1980) 1.04
Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma. Int J Cancer (2001) 1.04
Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents. Nucleic Acids Res (1995) 1.03
Beta-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels. J Physiol (2003) 1.03
Matrix metalloproteinase-assisted triggered release of liposomal contents. Bioconjug Chem (2007) 1.02
Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.01
Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group. Neurology (1992) 1.01
L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. Leukemia (1995) 1.00
Respiratory virus infections in pediatric hematopoietic stem cell transplantation. Clin Infect Dis (2001) 1.00
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer. Clin Infect Dis (2000) 1.00
The significance of triiodothyronine (T3) in maintenance of euthyroid status after treatment of hyperthyroidism. J Clin Endocrinol Metab (1971) 1.00
Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol (2001) 1.00
Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity. J Am Chem Soc (2006) 1.00
Direct transfer of reduced nicotinamide adenine dinucleotide from glyceraldehyde-3-phosphate dehydrogenase to liver alcohol dehydrogenase. Biochemistry (1984) 0.99
Longitudinal patterns of psychological distress in adult survivors of childhood cancer. Br J Cancer (2013) 0.99
Management of anorectal/perineal infections caused by Pseudomonas aeruginosa in children with malignant diseases. J Pediatr Surg (1991) 0.99
Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses. Hum Gene Ther (2004) 0.99
Hepatitis C infection among survivors of childhood cancer. Blood (2000) 0.98
Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2002) 0.98
5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids. J Physiol (2004) 0.98